Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.39B P/E - EPS this Y -20.90% Ern Qtrly Grth -
Income -93.72M Forward P/E -13.64 EPS next Y -40.00% 50D Avg Chg -25.00%
Sales - PEG -1.56 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 3.60 EPS next 5Y 40.00% 52W High Chg -46.00%
Recommedations 1.50 Quick Ratio 29.38 Shares Outstanding 110.27M 52W Low Chg 449.00%
Insider Own 6.04% ROA -12.78% Shares Float 104.29M Beta 1.10
Inst Own 71.69% ROE -17.55% Shares Shorted/Prior 11.15M/11.14M Price 13.91
Gross Margin - Profit Margin - Avg. Volume 2,851,827 Target Price 113.80
Oper. Margin - Earnings Date Jul 24 Volume 1,253,300 Change -1.77%
About Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics, Inc. News
04/26/24 Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
04/25/24 3 Millionaire-Maker Biotech Stocks
04/25/24 Q1 2024 Viking Therapeutics Inc Earnings Call
04/25/24 Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
04/24/24 Viking Therapeutics Reports First Quarter 2024 Results: Aligns with Analyst Projections
04/24/24 Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/24/24 Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
04/23/24 Brian Big Idea On Technical Analysis
04/23/24 Better Buy: Pfizer vs. Viking Therapeutics
04/19/24 Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights
04/19/24 Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
04/17/24 Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
04/16/24 These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
04/13/24 3 Magnificent Stocks That Could Double or More by 2030
04/12/24 Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
04/11/24 If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
04/11/24 3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
04/10/24 Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
04/10/24 What Makes Viking Therapeutics (VKTX) an Attractive Potential Opportunity?
04/09/24 Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
VKTX Chatroom

User Image FE123 Posted - 1 hour ago

$VKTX Lly earnings on Tuesday PreMarket, Does Lian drop Great Data also that Morning?

User Image FE123 Posted - 2 hours ago

$VKTX Lian loves to drop News on Tuesdays! Plus the Crazy amount of Calls bought on Friday! Give me over $100!!

User Image Axadude Posted - 7 hours ago

$VKTX Please can we do a wellness check on this delusional person !

User Image DG20 Posted - 8 hours ago

$VKTX I love these nonsense posts, especially when that have nearly $1B in cash. You can sense the desperation of shorts 🩳 starting…

User Image NoFearHere Posted - 8 hours ago

$VKTX you're crazy nothing's happening until after that shareholder meeting in May 13th so you might as well chill on my over speculation of a merger buyout I don't think it happens I hope it doesn't that's not what the most money is

User Image DG20 Posted - 8 hours ago

$VKTX You’re likely next in line if VKTX catches a BO…

User Image Nomoney76 Posted - 9 hours ago

$VKTX but did you though? It never hit $100+. Quit your cross posting bs.

User Image Diefreeandsell Posted - 10 hours ago

@BTECHINV why is $VKTX 8 bill market cap 16X higher than alt? Is $alt any closer to fda submission than vktx? If alt closer why such the disparity in mkt caps?

User Image ChristopherBrecher Posted - 11 hours ago

$VKTX I am hoping we get to buy this back near the 68 level.

User Image RonIsWrong Posted - 12 hours ago

$VKTX A good listen covering some of the obesity space in general, starting at the 10:45 mark, with biotech veteran Clive Meanwell (Former CEO of the Medicines Company), now CEO of startup Metsera. https://open.spotify.com/episode/7GUdSdIEUTVx8CrOjqEeWA?si=fdpLkWt7Td-TFfagFbhW4A&t=649 [Viking not mentioned]

User Image Bullishbruk Posted - 13 hours ago

$IBRX after holding for two long years, just right a week before it shot up to $100+ I sold all of my $VKTX shares avg $28.7sh, mind you I made a boat load of money but, I learn my lesson and at this time I am holding my $IBRX shares for a few more years and adding

User Image Lets_Go_Brndn Posted - 13 hours ago

$VKTX Based of several leading indicators including sentiment, strength of results, new larger price targets, CEO FOMO, shareholder advocacy - this week looks to be the push to triple figures. Pts keep rolling in AND it would be naive to not think discussions are taking place with acquirement hopefuls. Yes that’s plural. Shareholders of BP that don’t have obesity in their pipeline can probably sue for malpractice if their companies don’t tender serious offers. Ladies & Gentlemen- you are staring at a ticker that Bears will lie their butts off to help their soon to be broke asses. Help your fellow Bears declare bankruptcy and add more or just hold. “There is no better Bear than a broke Bear and the more broke bears there are- the better off the world is”. -Unknown

User Image Chipmonk1 Posted - 13 hours ago

$VKTX TJ max. Very simple. You are a mindless asshole

User Image Okenrav Posted - 14 hours ago

$VKTX I am just curious how your sick mind works...so you hope someone takes you seriously, they sell first thing Monday so you can succesfuly flash-short this a buck or two?

User Image AbraKeeperOfThe7Bees Posted - 14 hours ago

$VKTX Good luck to you Viking shareholders from an Altimmuner.

User Image Okenrav Posted - 15 hours ago

$VKTX $PFE can throw a P3 for 5211 in no time, anytime they want!

User Image Okenrav Posted - 15 hours ago

$VKTX Does he talk as if the drug was "shelved"

User Image Okenrav Posted - 15 hours ago

$VKTX You need to be exposed for the stupid crook that you are!

User Image Okenrav Posted - 15 hours ago

$VKTX It is simply amazing how you do not see the value of the SARM drug but, on the other hand, you're all in $IOVA piggybacking European P3s curing all cancer worldwide. GEt a fucking grip!

User Image Okenrav Posted - 15 hours ago

$VKTX You are a complete moron. This is not a drug for fatties. This is a drug for the bedridden (CNS injuries with prolonged comas, polytrauma patients), for those with chronic conditions (cancer on chemo, short gut syndrome, pancreatic insufficiency etc). These are real life saving medical indications with great demand and a big share of patients are medicare/medicaid covered - BILLIONS! Nobody in his right mind tries to link SARM with GLP. Moron!

User Image FE123 Posted - 16 hours ago

$VKTX Reminds me of $IMGN and huge Call buying before the Buyout few days Later!

User Image okiejames Posted - 17 hours ago

$VKTX 🤔

User Image Rdrydr Posted - 18 hours ago

$VKTX no way am I selling calls on this right now.

User Image Enthropy_22 Posted - 18 hours ago

$VKTX this is from X. ATTN: NEWS RELEASE FOR $VKTX @Viking_VKTX NASH Biopsy data release on Tuesday April 30th….guess what… at 7.03am EST. 😀Brian bring it baby! Release the kraken. $200 here we come! Can anyone confirm this?

User Image precise Posted - 19 hours ago

$VKTX Ok. Please do block. I still hold 10k shares. I am long. The SARM not being approvable has NOTHING to do with the long term potential of the weight loss drug. CEO even suggested it in last conference call that FDA is not going to approve a suppressive SARM in weight loss setting. Learn to distinguish hype from reality, numb nuts.

User Image Okenrav Posted - 19 hours ago

$VKTX $LLY are pussies. $PFE buys this. 300+

User Image Okenrav Posted - 19 hours ago

$VKTX evil peanut-sized smooth brain psychopath! Blocked👇🤮

User Image Robbullishious Posted - 21 hours ago

$VKTX the million $$$ question/guess is what info leaked to whom @ 1140AM CST, 0940AM PST (Viking HQ time)? SKOL!!

User Image Oracle888 Posted - 21 hours ago

$VKTX retail does not have these power to move this mulch unless is gamestock Something is brewing

User Image Rickerthestockpicker1 Posted - 22 hours ago

$VKTX Very

Analyst Ratings
HC Wainwright & Co. Buy Apr 25, 24
Oppenheimer Outperform Mar 27, 24
Oppenheimer Outperform Mar 26, 24
BTIG Buy Mar 26, 24
HC Wainwright & Co. Buy Mar 26, 24
Stifel Buy Mar 15, 24
BTIG Buy Mar 15, 24
Maxim Group Buy Mar 15, 24
HC Wainwright & Co. Buy Mar 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lian Brian President & CEO President & CEO Jan 31 Sell 24.7 85,000 2,099,500 2,264,882 01/31/24
Lian Brian President & CEO President & CEO Jan 31 Option 1.23 85,000 104,550 2,349,882 01/31/24
Lian Brian President & CEO President & CEO Jan 30 Sell 23.95 35,000 838,250 2,264,882 01/30/24
Lian Brian President & CEO President & CEO Jan 30 Option 1.23 35,000 43,050 2,299,882 01/30/24
Rouan Sarah Kathryn Director Director Jan 19 Sell 23.05 30,000 691,500 01/19/24
Rouan Sarah Kathryn Director Director Jan 19 Option 8.32 30,000 249,600 30,000 01/19/24
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Jan 03 Sell 17.9 15,000 268,500 180,730 01/04/24
Rowland Charles A Jr Director Director May 16 Option 1.08 40,000 43,200 70,000 05/18/23
Rowland Charles A Jr Director Director May 16 Sell 25 40,000 1,000,000 30,000 05/18/23
MACARTNEY LAWSON Director Director May 16 Sell 24 16,000 384,000 47,965 05/18/23
MACARTNEY LAWSON Director Director May 16 Option 1.19 16,000 19,040 63,965 05/18/23
Lian Brian President & CEO President & CEO May 01 Sell 22.45 45,000 1,010,250 2,197,963 05/01/23
MACARTNEY LAWSON Director Director Apr 24 Sell 22 16,000 352,000 47,965 04/24/23
MACARTNEY LAWSON Director Director Apr 24 Option 3.33 16,000 53,280 63,965 04/24/23
Lian Brian President & CEO President & CEO Apr 19 Sell 21.45 35,000 750,750 2,242,963 04/21/23
MACARTNEY LAWSON Director Director Apr 17 Sell 20 20,786 415,720 47,965 04/18/23
MACARTNEY LAWSON Director Director Apr 17 Option 8 20,786 166,288 68,751 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Sell 20.45 155,000 3,169,750 2,277,963 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Option 2.15 125,000 268,750 2,432,963 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Sell 20 12,500 250,000 287,763 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Option 13.07 12,500 163,375 300,263 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Sell 20 7,500 150,000 149,279 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Option 13.07 7,500 98,025 156,779 04/18/23
Lian Brian President & CEO President & CEO Apr 13 Sell 18.45 79,336 1,463,749 2,307,963 04/13/23
Lian Brian President & CEO President & CEO Apr 13 Option 1.88 54,336 102,152 2,387,299 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Sell 18 97,839 1,761,102 149,279 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Option 6.12 97,839 598,775 190,823 04/13/23
Lian Brian President & CEO President & CEO Mar 30 Sell 17.43 243,352 4,241,625 2,232,963 04/03/23
Lian Brian President & CEO President & CEO Mar 30 Option 6.74 203,352 1,370,592 2,322,933 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Sell 17.5 161,940 2,833,950 147,778 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Option 6.55 124,661 816,530 178,689 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 30 Option 9.92 72,200 716,224 261,895 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Sell 15.5 237,805 3,685,978 261,895 03/30/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Option 2.98 182,427 543,632 303,137 03/30/23